This inventor holds 4 USPTO granted patents and 1 published patent application and 3 EPO patents. Top assignees: Senju Pharmaceutical Co., Ltd., Mitsubishi Tanabe Pharma Corporation, Mitsubishi Pharma Corporation. Active years: 2006-2011.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:

Years Active: 2006-2011
Title: Innovations by Yoshiko Takayama
Introduction
Yoshiko Takayama is a prominent inventor based in Kobe, Japan. She has made significant contributions to the field of ophthalmology through her innovative inventions. With a total of 4 patents, her work focuses on improving visual function and corneal sensitivity.
Latest Patents
One of her latest patents is an agent for repairing corneal sensitivity containing an amide compound. This compound promotes neuritogenesis of trigeminal nerve cells, making it useful for recovering corneal sensitivity and treating dry eye. Another notable invention is a visual function disorder improving agent that contains a compound with Rho kinase inhibitory activity. This agent promotes the extension of retinal ganglion cell axons and optic nerve cell regeneration, aiding in the treatment of visual function disorders associated with various eye diseases.
Career Highlights
Yoshiko has worked with notable companies such as Senju Pharmaceutical Co., Ltd. and Mitsubishi Tanabe Pharma Corporation. Her experience in these organizations has allowed her to develop and refine her innovative ideas in the pharmaceutical industry.
Collaborations
Throughout her career, Yoshiko has collaborated with esteemed colleagues, including Masayoshi Uehata and Yoshikuni Nakamura. These partnerships have contributed to her success and the advancement of her inventions.
Conclusion
Yoshiko Takayama's contributions to the field of ophthalmology through her patents demonstrate her commitment to innovation and improving patient care. Her work continues to inspire advancements in visual health.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile